William D. Bradley

Antitumor Activity of BRAF Inhibitor Vemurafenib in Preclinical Models of BRAF-Mutant Colorectal Cancer

Hong Yang, Brian Higgins, Kenneth Kolinsky et al. · Cancer Research · 2011 · 217 citations · Full text

Medicine, Oncology, Pharmacology +15

Regulation of cell migration and morphogenesis by Abl-family kinases: emerging mechanisms and physiological contexts

William D. Bradley, Anthony J. Koleske · Journal of Cell Science · 2009 · 178 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Resistance to Selective BRAF Inhibition Can Be Mediated by Modest Upstream Pathway Activation

Fei Su, William D. Bradley, Qiongqing Wang et al. · Cancer Research · 2011 · 177 citations

Medicine, Molecular Biology, Oncology +17

EZH2 Inhibitor Efficacy in Non-Hodgkin’s Lymphoma Does Not Require Suppression of H3K27 Monomethylation

William D. Bradley, Shilpi Arora, Jennifer Busby et al. · Chemistry & Biology · 2014 · 148 citations

Medicine, Oncology, Pharmacology +11

Inhibition of Rho via Arg and p190RhoGAP in the Postnatal Mouse Hippocampus Regulates Dendritic Spine Maturation, Synapse and Dendrite Stability, and Behavior

Mindan K. Sfakianos, Aaron S. Eisman, Shannon L. Gourley et al. · Journal of Neuroscience · 2007 · 124 citations · Full text

Medicine, Neurobiology, Neuroscience +17